Back to Authors

Herrera, Alex F.

https://orcid.org/0000-0002-9665-7415

Mayo Clinic

City Of Hope National Medical Center

Citations 66

INVESTIGATING SAFETY AND PRELIMINARY EFFICACY OF AFM13 PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE
Ansell, Stephen M. , Chen, R.W., Herrera, Alex F. , Forero‐Torres, Andres , Armand, Philippe , Devata, Sumana, Izquierdo, Antonia Rodríguez, Lossos, Izidore S. , Reeder, Craig B. , Sher, Taimur , Choe-Juliak, Cassandra, Prier, Kim, Schwarz, Sylvia E., Strassz, András, Alland, Leila, Bartlett, Nancy L. , Domingo‐Doménech, Eva , Mehta, Amitkumar , García‐Sánz, Ramón

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 177-178

10.1002/hon.134_2629 Get It

Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation
Kanate, Abraham S. , Kumar, Ambuj , Dreger, Peter , Dreyling, Martin, Gouill, Steven Le , Bredeson, Christopher , Fenske, Timothy S. , Smith, Sonali M. , Sureda, Anna , Moskowitz, Alison J. , Friedberg, Jonathan W. , Inwards, David J. , Herrera, Alex F. , Kharfan‐Dabaja, Mohamed A. , Reddy, Nishitha , Montoto, Silvia , Abutalib, Syed A., Gisselbrecht, Christian , Carpenter, Paul A. , Kharfan-Dabaja, Mohamed A., Montoto, Silvia , Dreyling, Martin, Corradini, Paolo , Robinson, Stephen Paul , Vose, Julie M. , Gopal, Ajay K. , Shadman, Mazyar , Perales, Miguel‐Angel , Savani, Bipin N. , Hamadani, Mehdi

JAMA Oncology | February 28, 2019 | Volume: 5 | Issue: 5 | Pages: 715

10.1001/jamaoncol.2018.6278 Get It

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis
Shah, Nirav N. , Ahn, Kwang Woo , Litovich, Carlos, Fenske, Timothy S. , Ahmed, Sairah , Bejanyan, Nelli , Bolaños‐Meade, Javier , Chen, Andy I. , Ciurea, Stefan O. , Bachanová, Veronika , DeFilipp, Zachariah , Epperla, Narendranath , Farhadfar, Nosha , Herrera, Alex F. , Haverkos, Bradley M. , Holmberg, Leona , Hossain, Nasheed , Kharfan‐Dabaja, Mohamed A. , Kenkre, Vaishalee P. , Murthy, Hemant S. , Rezvani, Andrew R. , D’Souza, Anita , Ulrickson, Matthew L. , Waller, Edmund K. , Sureda, Anna , Smith, Sonali M. , Holmberg, Leona , Chen, Andy , Kharfan-Dabaja, Mohamed A., D'Souza, Anita , Bachanova, Veronika , Murthy, Hemant S , Waller, Edmund K , Epperla, Narendranath , Ahmed, Sairah , Battiwalla, Minoo , Dahi, Parastoo B , Lazarus, Hillard M. , Nishihori, Taiga , Savani, Bipin N. , Hamadani, Mehdi

Blood Advances | April 23, 2018 | Volume: 2 | Issue: 8 | Pages: 933-940

10.1182/bloodadvances.2018018531 Get It

Key Points There was no difference in overall survival after allogeneic transplant between patients aged 55-64 years and patients ≥65 years. Age alone should not be a determinant for allogeneic transplant eligibility among older non-Hodgkin lymphoma patients.
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
Herrera, Alex F. , Moskowitz, Alison J. , Bartlett, Nancy L. , Ramchandren, Radhakrishnan , Feldman, Tatyana , LaCasce, Ann S. , Ansell, Stephen M. , Moskowitz, Craig H. , Fenton, Keenan , Ogden, Carol Anne, Zhang, Qu , Kato, Kazunobu, Campbell, Mary S., Advani, Ranjana H. , Bartlett, Nancy L , Advani, Ranjana H , Vose, Julie M. , Taft, David R.

Blood | December 11, 2017 | Volume: 131 | Issue: 11 | Pages: 1183-1194

10.1182/blood-2017-10-811224 Get It

Key Points BV and Nivo were well-tolerated in patients with R/R HL, with less than 10% of patients treated with systemic steroids for immune-related AEs. The complete response rate was 61% (82% objective response rate), and patients were able to undergo stem cell transplant without adverse impact.
CHECKMATE 647: A PHASE 2, OPEN‐LABEL STUDY OF NIVOLUMAB IN RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA OR RELAPSED/REFRACTORY PRIMARY TESTICULAR LYMPHOMA
Nayak, Lakshmi , Ferreri, Andrés J.M. , Batlevi, Connie Lee , Batchelor, Tracy T. , Rubenstein, James L. , Johnston, Patrick B. , Ramchandren, Radhakrishnan , Soussain, Carole , Becker, Kevin, Illerhaus, Gerald , Herrera, Alex F. , Masood, Aisha, IWAMOTO, FABIO MASSAITI , Santoro, Armando , Singer, Samuel , Drappatz, Jan , Witzens‐Harig, Mathias , Shipp, Margaret Ann

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 420-421

10.1002/hon.2440_2 Get It

INTERIM RESULTS FROM a PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA
Herrera, Alex F. , Moskowitz, Alison J. , Ramchandren, Radhakrishnan , Feldman, Tatyana , LaCasce, Ann S. , Ansell, Stephen M. , Moskowitz, Craig H. , Fenton, Keenan , Ogden, Carol Anne, Zhang, Q. , Kato, Kazunobu, Campbell, Mary S., Bartlett, Nancy L. , Vose, Julie M. , Taft, David R. , Advani, Ranjana H.

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 85-86

10.1002/hon.2437_73 Get It